NMRA · Company research
Neumora Therapeutics, Inc. Common Stock (NMRA): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
17records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) - What Are Researchers Thinking About This Stock? - MarketBeat | Neumora Therapeutics, Inc. (NMRA) - What Are Researchers Thinking About This Stock? MarketBeat | View source ↗ | MarketBeat | Oct 14, 2026 | neutral | 0 | 0.6 |
| NMRA Stock On Track For Worst Day In 1.5 Years — Neumora Therapeutics' Lead Depression Drug Fails Late Stage Trials - Stocktwits | NMRA Stock On Track For Worst Day In 1.5 Years — Neumora Therapeutics' Lead Depression Drug Fails Late Stage Trials Stocktwits | View source ↗ | Stocktwits | Oct 12, 2026 | neutral | 0 | 0.6 |
| Neumora Therapeutics (NASDAQ:NMRA) Cut to Strong Sell at Wall Street Zen - MarketBeat | Neumora Therapeutics (NASDAQ:NMRA) Cut to Strong Sell at Wall Street Zen MarketBeat | View source ↗ | MarketBeat | Oct 10, 2026 | neutral | 0 | 0.6 |
| Neumora Therapeutics Inc (NMRA-Q) Stock Price and News - The Globe and Mail | Neumora Therapeutics Inc (NMRA-Q) Stock Price and News The Globe and Mail | View source ↗ | The Globe and Mail | Oct 2, 2026 | neutral | 0 | 0.6 |
| Biotech Options Buzz: UTHR, NMRA, EWTX - Schaeffer's Investment Research | Biotech Options Buzz: UTHR, NMRA, EWTX Schaeffer's Investment Research | View source ↗ | Schaeffer's Investment Research | Sep 18, 2026 | neutral | 0 | 0.6 |
| Insiders Sold Neumora Therapeutics Prematurely At US$2.29 With Stock Trading Higher - Simply Wall St | Insiders Sold Neumora Therapeutics Prematurely At US$2.29 With Stock Trading Higher Simply Wall St | View source ↗ | Simply Wall St | Aug 29, 2026 | neutral | 0 | 0.6 |
| Neumora Names Joshua Pinto CEO as 2026 Clinical Milestones Near - Stock Titan | Neumora Names Joshua Pinto CEO as 2026 Clinical Milestones Near Stock Titan | View source ↗ | Stock Titan | Aug 14, 2026 | neutral | 0 | 0.6 |
| Neumora Therapeutics Reports Second Quarter 2026 Results and Advances Pipeline Amid Leadership Changes - Quiver Quantitative | Neumora Therapeutics Reports Second Quarter 2026 Results and Advances Pipeline Amid Leadership Changes Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 14, 2026 | neutral | 0 | 0.6 |
| Neumora Therapeutics (NMRA) Stock Sees Fair Value Falls After Navacaprant Discontinuation - Yahoo Finance | Neumora Therapeutics (NMRA) Stock Sees Fair Value Falls After Navacaprant Discontinuation Yahoo Finance | View source ↗ | Yahoo Finance | Jul 11, 2026 | neutral | 0 | 0.6 |
| Why Neumora Therapeutics, Inc. (NMRA) Is One of the Best Get Rich Quick Stocks to Buy - Yahoo Finance | Why Neumora Therapeutics, Inc. (NMRA) Is One of the Best Get Rich Quick Stocks to Buy Yahoo Finance | View source ↗ | Yahoo Finance | Jul 7, 2026 | neutral | 0 | 0.6 |
| NMRA Stock Drops As Neumora Axes Failed Depression Drug - timothysykes.com | NMRA Stock Drops As Neumora Axes Failed Depression Drug timothysykes.com | View source ↗ | timothysykes.com | Jun 28, 2026 | neutral | 0 | 0.6 |
| NMRA Forecast — Price Target — Prediction for 2027 - TradingView | NMRA Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| NMRA Investor Alert: Levi & Korsinsky Investigates Neumora Therapeutics (NMRA) for Potential Securities Fraud - Business Wire | NMRA Investor Alert: Levi & Korsinsky Investigates Neumora Therapeutics (NMRA) for Potential Securities Fraud Business Wire | View source ↗ | Business Wire | Jun 18, 2026 | neutral | 0 | 0.6 |
| Neumora Therapeutics Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Neumora Therapeutics (NMRA) - PR Newswire | Neumora Therapeutics Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Neumora Therapeutics (NMRA) PR Newswire | View source ↗ | PR Newswire | Jun 16, 2026 | neutral | 0 | 0.6 |
| Should I buy Neumora Therapeutics, Inc. (NMRA) - Zacks Investment Research | Should I buy Neumora Therapeutics, Inc. (NMRA) Zacks Investment Research | View source ↗ | Zacks Investment Research | Jun 16, 2026 | neutral | 0 | 0.6 |
| NMRA Stock Price and Chart — NASDAQ:NMRA - TradingView | NMRA Stock Price and Chart — NASDAQ:NMRA TradingView | View source ↗ | TradingView | Apr 18, 2026 | neutral | 0 | 0.6 |
| Neumora Therapeutics (NMRA) Is Among the Best Penny Stocks Set to Explode - Yahoo Finance | Neumora Therapeutics (NMRA) Is Among the Best Penny Stocks Set to Explode Yahoo Finance | View source ↗ | Yahoo Finance | Apr 12, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.